These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

735 related articles for article (PubMed ID: 27765808)

  • 1. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
    Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B; Zhang JC; Han M; Yao W; Yang C; Ren Q; Ma M; Chen QX; Hashimoto K
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3647-57. PubMed ID: 27488193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC; Yao W; Dong C; Yang C; Ren Q; Ma M; Han M; Hashimoto K
    Psychopharmacology (Berl); 2015 Dec; 232(23):4325-35. PubMed ID: 26337614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like actions of the mGlu2/3 receptor antagonist TP0178894 in the chronic social defeat stress model: Comparison with escitalopram.
    Dong C; Tian Z; Fujita Y; Fujita A; Hino N; Iijima M; Hashimoto K
    Pharmacol Biochem Behav; 2022 Jan; 212():173316. PubMed ID: 34968554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.
    Karasawa J; Shimazaki T; Kawashima N; Chaki S
    Brain Res; 2005 Apr; 1042(1):92-8. PubMed ID: 15823257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX; Wang J; Xie ZM; Xu N; Zhang GF; Jia M; Zhou ZQ; Hashimoto K; Yang JJ
    Psychopharmacology (Berl); 2016 Feb; 233(3):405-15. PubMed ID: 26514555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.
    Zhang JC; Wu J; Fujita Y; Yao W; Ren Q; Yang C; Li SX; Shirayama Y; Hashimoto K
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25628381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects.
    Yang C; Shirayama Y; Zhang JC; Ren Q; Yao W; Ma M; Dong C; Hashimoto K
    Transl Psychiatry; 2015 Sep; 5(9):e632. PubMed ID: 26327690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
    Chaki S; Yoshikawa R; Hirota S; Shimazaki T; Maeda M; Kawashima N; Yoshimizu T; Yasuhara A; Sakagami K; Okuyama S; Nakanishi S; Nakazato A
    Neuropharmacology; 2004 Mar; 46(4):457-67. PubMed ID: 14975669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA
    Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
    Xiong Z; Zhang K; Ishima T; Ren Q; Ma M; Pu Y; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jan; 176():57-62. PubMed ID: 30502360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model.
    Zhang K; Dong C; Fujita Y; Fujita A; Hashimoto K
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):157-163. PubMed ID: 29155989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.
    Jiang B; Wang F; Yang S; Fang P; Deng ZF; Xiao JL; Hu ZL; Chen JG
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25522427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in the brain regions of a learned helplessness rat model and the antidepressant effects of a TrkB agonist and antagonist.
    Shirayama Y; Yang C; Zhang JC; Ren Q; Yao W; Hashimoto K
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2449-58. PubMed ID: 26419294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
    Pałucha-Poniewiera A; Wierońska JM; Brański P; Stachowicz K; Chaki S; Pilc A
    Psychopharmacology (Berl); 2010 Dec; 212(4):523-35. PubMed ID: 20703449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling.
    Wei Y; Chang L; Hashimoto K
    Eur Neuropsychopharmacol; 2021 Sep; 50():55-63. PubMed ID: 33971385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.